Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities.The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.
神经治疗学®是美国实验神经治疗学会（ASENT）的期刊。每一期都对国际权威撰写的神经疾病治疗相关的重要主题进行评论。该杂志还发表转化神经科学的原创研究文章，包括对跨学科前沿疗法的描述，并代表了该领域医生和其他研究人员对神经治疗学的重要贡献。Neurotherapeutics ®提供了转化神经科学前沿的多学科视角，提供了当前研究和实践的视角，涵盖了社会和伦理以及科学问题。
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00767-8
Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson’s Disease Mice via Gut Microbiota and Metabolites
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00719-2
Treatment Responsiveness in KCNT1-Related Epilepsy
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00739-y
Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00761-0
Activation of Melanocortin 1 Receptor Attenuates Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage viathe Suppression of Neuroinflammation through AMPK/TBK1/NF-κB Pathway in Rats
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00772-x
Molecular Mechanisms and Therapeutics for the GAA·TTC Expansion Disease Friedreich Ataxia
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00764-x
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00776-7
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00723-6
Consequences of Metabolic Disruption in Alzheimer’s Disease Pathology
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00755-y
Antisense Oligonucleotides for the Treatment of Inner Ear Dysfunction
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00729-0
Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00784-7
Plasma-Based Strategies for Therapeutic Modulation of Brain Aging
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00746-z
A Longitudinal Study of the Neurologic Safety of Acute Baclofen Use After Spinal Cord Injury
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00713-8
FG-4592 Improves Depressive-Like Behaviors through HIF-1-Mediated Neurogenesis and Synapse Plasticity in Rats
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00807-3
A New Era for Surgical Neurotherapeutics
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00709-4
Blood Pressure Control and Protection of the Aging Brain
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00747-y
Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00808-2
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00802-8
Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00775-8
Molecular Mechanisms and Future Therapeutics for Spinocerebellar Ataxia Type 31 (SCA31)
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00804-6
Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson’s Disease Model Mice
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00732-5
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00765-w
Repeat Expansion Disorders: Mechanisms and Therapeutics
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00823-3
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00786-5
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00781-w
Glial Cell Line–Derived Neurotrophic Factor and Chondroitinase Promote Axonal Regeneration in a Chronic Denervation Animal Model
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00745-0
Induction of Neuronal PI3Kγ Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00748-x
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00721-8
Moving Towards Therapy in SCA1: Insights from Molecular Mechanisms, Identification of Novel Targets, and Planning for Human Trials
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00763-y
Intranasal Neuropeptide Y Blunts Lipopolysaccharide-Evoked Sickness Behavior but Not the Immune Response in Mice
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00758-9
Subcutaneous administration of β-hydroxybutyrate improves learning and memory of sepsis surviving mice
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00806-4
Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00780-x
Correction to: Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson’s Disease Model Mice
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00760-1
Long Noncoding RNA HOTAIRM1 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells Through Regulation of HOX Gene Expression
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00799-0
Opioid Craving in Human Laboratory Settings: a Review of the Challenges and Limitations
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00791-8
Perfusion Enhancement with Respiratory Impedance After Stroke (PERI-Stroke)
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00744-1
Alcohol Use Disorder Interventions Targeting Brain Sites for Both Conditioned Reward and Delayed Gratification
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00817-1
At-Home Cortical Stimulation for Neuropathic Pain: a Feasibility Study with Initial Clinical Results
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00734-3
Molecular Signatures of the Aging Brain: Finding the Links Between Genes and Phenotypes
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00743-2
Receptor Tyrosine Kinases as Therapeutic Targets for Alcohol Use Disorder
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00795-4
Dalfampridine to Improve Balance in Multiple Sclerosis: Substudy from a Randomized Placebo-Controlled Trial
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00813-5
Tuberous Sclerosis (tsc2+/-) Model Eker Rats Reveals Extensive Neuronal Loss with Microglial Invasion and Vascular Remodeling Related to Brain Neoplasia
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00812-6
Abstracts from HSG 2019
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00788-3
Long-Term Follow-up in Patients with Spontaneous Intracerebral Hemorrhage Treated With or Without Surgical Intervention: a Large-Scale Retrospective Study
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00722-7
Autoimmune Epilepsy
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00750-3
Adhering to Ethical Benchmarks in Neurology Clinical Trials Using iPSCs
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00728-1
Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00718-3
Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00796-3
Brain–Machine Interface Induced Morpho-Functional Remodeling of the Neural Motor System in Severe Chronic Stroke
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00816-2
One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial
来源期刊：NeurotherapeuticsDOI：10.1007/s13311-019-00818-0
